Polfa Kutno post bumper march profit

Polfa Kutno, the leading national producer of pharmaceuticals, recorded zł.39 million in revenues and a zł.15.3 million net profit in March. However, according to the company's spokesman Krzysztof Kouyoumdjian, "Such a high net profit is due to the fact that at the end of the quarter our sales accounts accumulate." He admitted that the company usually records similar results in December. In Q1 Polfa generated the revenues of zł.43 million, with a zł.1.09 million net profit. The firm's financial results for Q2 will be announced on August 4. The company's management board has also decided to start publishing a financial statement every month. (Parkiet, p. 5) A.F.